However, miR-429 (26), miR-125a/b/miR-124 (55) and miR-605-3p (56) were confirmed to dampen the expression of NF-κB target genes by targeting TRAF6, which significantly abrogated the malignancy of HCC. This evidence concerns the gene TRAF6 and hepatocellular carcinoma.